These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16474176)

  • 1. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
    Heikkinen K; Rapakko K; Karppinen SM; Erkko H; Knuutila S; Lundán T; Mannermaa A; Børresen-Dale AL; Borg A; Barkardottir RB; Petrini J; Winqvist R
    Carcinogenesis; 2006 Aug; 27(8):1593-9. PubMed ID: 16474176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
    Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.
    Bartkova J; Tommiska J; Oplustilova L; Aaltonen K; Tamminen A; Heikkinen T; Mistrik M; Aittomäki K; Blomqvist C; Heikkilä P; Lukas J; Nevanlinna H; Bartek J
    Mol Oncol; 2008 Dec; 2(4):296-316. PubMed ID: 19383352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.
    He M; Di GH; Cao AY; Hu Z; Jin W; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 May; 133(1):111-6. PubMed ID: 21811815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
    Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
    Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotypic variation in MRE11, RAD50 and NBS1 and risk of non-Hodgkin's lymphoma.
    Rollinson S; Kesby H; Morgan GJ
    Leuk Lymphoma; 2006 Dec; 47(12):2567-83. PubMed ID: 17169801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia.
    Mosor M; Ziółkowska-Suchanek I; Nowicka K; Dzikiewicz-Krawczyk A; Januszkiewicz-Lewandowska D; Nowak J
    BMC Cancer; 2013 Oct; 13():457. PubMed ID: 24093751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population.
    Uhrhammer N; Delort L; Bignon YJ
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):684-5. PubMed ID: 19190165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MRE11/RAD50/NBS1 complex destabilization in Lynch-syndrome patients.
    Alemayehu A; Fridrichova I
    Eur J Hum Genet; 2007 Sep; 15(9):922-9. PubMed ID: 17534377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer.
    Dzikiewicz-Krawczyk A
    Mutat Res; 2008; 659(3):262-73. PubMed ID: 18606567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
    Khan RT; Siddique A; Shahid N; Khokher S; Fatima W
    Breast Cancer; 2018 May; 25(3):350-355. PubMed ID: 29368209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.
    Allen-Brady K; Camp NJ
    BMC Cancer; 2005 Aug; 5():99. PubMed ID: 16091150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
    Rebbeck TR; Mitra N; Domchek SM; Wan F; Chuai S; Friebel TM; Panossian S; Spurdle A; Chenevix-Trench G; ; Singer CF; Pfeiler G; Neuhausen SL; Lynch HT; Garber JE; Weitzel JN; Isaacs C; Couch F; Narod SA; Rubinstein WS; Tomlinson GE; Ganz PA; Olopade OI; Tung N; Blum JL; Greenberg R; Nathanson KL; Daly MB
    Cancer Res; 2009 Jul; 69(14):5801-10. PubMed ID: 19584272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.
    Schuetz JM; MaCarthur AC; Leach S; Lai AS; Gallagher RP; Connors JM; Gascoyne RD; Spinelli JJ; Brooks-Wilson AR
    BMC Med Genet; 2009 Nov; 10():117. PubMed ID: 19917125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of RAD50 in familial breast cancer predisposition.
    Tommiska J; Seal S; Renwick A; Barfoot R; Baskcomb L; Jayatilake H; Bartkova J; Tallila J; Kaare M; Tamminen A; Heikkilä P; Evans DG; Eccles D; Aittomäki K; Blomqvist C; Bartek J; Stratton MR; Nevanlinna H; Rahman N
    Int J Cancer; 2006 Jun; 118(11):2911-6. PubMed ID: 16385572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
    Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
    Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer.
    Cao AY; Hu Z; Yin WJ; Jin W; Shao ZM
    Breast Cancer Res Treat; 2010 May; 121(1):247-9. PubMed ID: 19904603
    [No Abstract]   [Full Text] [Related]  

  • 18. RAD50/MRE11/NBS1 proteins in relation to tumour development and prognosis in patients with microsatellite stable colorectal cancer.
    Gao J; Zhang H; Arbman G; Sun XF
    Histol Histopathol; 2008 Dec; 23(12):1495-502. PubMed ID: 18830935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies.
    Aloraifi F; McCartan D; McDevitt T; Green AJ; Bracken A; Geraghty J
    Cancer Genet; 2015 Sep; 208(9):455-63. PubMed ID: 26250988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.
    Debniak T; Górski B; Cybulski C; Jakubowska A; Kurzawski G; Lener M; Mierzejewski M; Masojć B; Medrek K; Kładny J; Załuga E; Maleszka R; Chosia M; Lubiński J
    Melanoma Res; 2003 Aug; 13(4):365-70. PubMed ID: 12883362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.